Prosight Management, LP Rocket Pharmaceuticals, Inc. Transaction History
Prosight Management, LP
- $337 Million
- Q4 2024
A detailed history of Prosight Management, LP transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Prosight Management, LP holds 1,088,706 shares of RCKT stock, worth $10.3 Million. This represents 4.06% of its overall portfolio holdings.
Number of Shares
1,088,706
Previous 159,369
583.14%
Holding current value
$10.3 Million
Previous $2.94 Million
365.0%
% of portfolio
4.06%
Previous 0.79%
Shares
7 transactions
Others Institutions Holding RCKT
# of Institutions
244Shares Held
108MCall Options Held
262KPut Options Held
159K-
Rtw Investments, LP New York, NY17.7MShares$167 Million3.63% of portfolio
-
Wellington Management Group LLP Boston, MA14MShares$132 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.58MShares$62.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$58.5 Million0.0% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx5.2MShares$49.1 Million1.26% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $715M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...